These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25578370)

  • 1. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles.
    Martín-Sabroso C; Fraguas-Sánchez AI; Aparicio-Blanco J; Cano-Abad MF; Torres-Suárez AI
    Int J Pharm; 2015 Mar; 480(1-2):27-36. PubMed ID: 25578370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
    Ahmed AR; Bodmeier R
    Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term controlled release of PLGA microparticles containing antidepressant mirtazapine.
    Vysloužil J; Doležel P; Kejdušová M; Košťál V; Beneš L; Dvořáčková K
    Pharm Dev Technol; 2016 Mar; 21(2):214-21. PubMed ID: 25495857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.
    Gu B; Burgess DJ
    Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
    Crotts G; Park TG
    J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique].
    Zhou XL; He JT; Zhou ZT; Ma SF; Jiang Y; Wang Y
    Yao Xue Xue Bao; 2010 Aug; 45(8):1057-63. PubMed ID: 21351596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges.
    Ramazani F; Chen W; van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ
    Int J Pharm; 2016 Feb; 499(1-2):358-367. PubMed ID: 26795193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of formulation and process parameters on the characteristics of PLGA-based microparticles with controlled drug release.
    Vysloužil J; Kejdušová M; Dvořáčkov K; Vetchý D
    Ceska Slov Farm; 2013 Jun; 62(3):120-6. PubMed ID: 23961813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
    Cocks E; Alpar O; Somavarapu S; Greenleaf D
    Drug Dev Ind Pharm; 2015 Mar; 41(3):522-8. PubMed ID: 24650006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
    He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
    Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.